28501028|t|Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report
28501028|a|Castleman disease is a rare lymphoproliferative disorder presenting with localized or disseminated lymphadenopathy and systemic manifestations. It can be categorized in numerous ways, such as unicentric versus multicentric, histopathological variants (hyaline - vascular, plasma cell, and mixed), or subtypes based on causative viral infections (human immunodeficiency virus, human herpesvirus-8, or Kaposi sarcoma herpesvirus). Presentation ranges from asymptomatic to symptoms involving multiple organs. Even though the exact mechanism of pathogenesis is unknown, treatment is directed toward possible etiologies such as interleukin-6, cluster of differentiation 20, and viral agents. A 36- year -old Sri Lankan woman presented with generalized body swelling and foamy urine of 2 weeks ' duration. Examination revealed pallor; generalized edema; axillary, cervical, and inguinal lymphadenopathy; hypertension; and hepatomegaly. Investigations showed bicytopenia, nephrotic range proteinuria with hypoalbuminemia, hypogammaglobulinemia, and features of hyaline - vascular type Castleman disease in a lymph node biopsy. She was managed with rituximab and had good clinical improvement. Castleman disease has a broad spectrum of clinical manifestations, disease pathogeneses, and associations and/or complications. Medical professionals need to be familiar with this spectrum because timely diagnosis and aggressive targeted therapy are the cornerstones of managing these patients.
28501028	0	30	Multicentric Castleman disease	T038	UMLS:C1334815
28501028	34	41	hyaline	T031	UMLS:C0020191
28501028	42	50	vascular	T017	UMLS:C0005847
28501028	110	121	case report	T170	UMLS:C0007320
28501028	122	139	Castleman disease	T038	UMLS:C1334815
28501028	150	178	lymphoproliferative disorder	T038	UMLS:C0024314
28501028	195	204	localized	T082	UMLS:C0392752
28501028	208	220	disseminated	T082	UMLS:C0205221
28501028	221	236	lymphadenopathy	T038	UMLS:C0497156
28501028	276	287	categorized	T170	UMLS:C0008902
28501028	314	324	unicentric	T038	UMLS:C0017531
28501028	332	344	multicentric	T038	UMLS:C1334815
28501028	374	381	hyaline	T031	UMLS:C0020191
28501028	384	392	vascular	T017	UMLS:C0005847
28501028	394	405	plasma cell	T017	UMLS:C0032112
28501028	440	449	causative	T033	UMLS:C0449411
28501028	450	466	viral infections	T038	UMLS:C0042769
28501028	468	496	human immunodeficiency virus	T005	UMLS:C0019682
28501028	498	517	human herpesvirus-8	T005	UMLS:C0376526
28501028	522	548	Kaposi sarcoma herpesvirus	T005	UMLS:C0376526
28501028	576	588	asymptomatic	T033	UMLS:C0231221
28501028	592	600	symptoms	T033	UMLS:C1457887
28501028	620	626	organs	T017	UMLS:C0178784
28501028	663	675	pathogenesis	T038	UMLS:C0699748
28501028	745	758	interleukin-6	T103	UMLS:C0021760
28501028	760	789	cluster of differentiation 20	T103	UMLS:C0054946
28501028	825	835	Sri Lankan	T098	UMLS:C1553327
28501028	836	841	woman	T098	UMLS:C0043210
28501028	869	882	body swelling	T033	UMLS:C0577596
28501028	922	933	Examination	T058	UMLS:C0582103
28501028	943	949	pallor	T033	UMLS:C0030232
28501028	951	968	generalized edema	T033	UMLS:C1850534
28501028	970	978	axillary	T082	UMLS:C0004454
28501028	980	988	cervical	T082	UMLS:C0205064
28501028	994	1018	inguinal lymphadenopathy	T038	UMLS:C0578736
28501028	1020	1032	hypertension	T038	UMLS:C0020538
28501028	1038	1050	hepatomegaly	T033	UMLS:C0019209
28501028	1052	1066	Investigations	T058	UMLS:C1261322
28501028	1074	1085	bicytopenia	T033	UMLS:C1142446
28501028	1087	1114	nephrotic range proteinuria	T033	UMLS:C0445118
28501028	1120	1135	hypoalbuminemia	T038	UMLS:C0239981
28501028	1137	1158	hypogammaglobulinemia	T038	UMLS:C0086438
28501028	1176	1183	hyaline	T031	UMLS:C0020191
28501028	1186	1194	vascular	T017	UMLS:C0005847
28501028	1200	1217	Castleman disease	T038	UMLS:C1334815
28501028	1223	1240	lymph node biopsy	T058	UMLS:C0193842
28501028	1250	1257	managed	T058	UMLS:C0086583
28501028	1263	1272	rituximab	T103	UMLS:C0393022
28501028	1308	1325	Castleman disease	T038	UMLS:C1334815
28501028	1332	1337	broad	T082	UMLS:C0332464
28501028	1375	1382	disease	T038	UMLS:C0012634
28501028	1383	1395	pathogeneses	T038	UMLS:C0699748
28501028	1421	1434	complications	T038	UMLS:C0009566
28501028	1444	1457	professionals	T097	UMLS:C1704312
28501028	1512	1521	diagnosis	T033	UMLS:C0011900
28501028	1526	1553	aggressive targeted therapy	T058	UMLS:C2985566